MA24383A1 - Derives pyridinium de cephalosporine - Google Patents

Derives pyridinium de cephalosporine

Info

Publication number
MA24383A1
MA24383A1 MA24842A MA24842A MA24383A1 MA 24383 A1 MA24383 A1 MA 24383A1 MA 24842 A MA24842 A MA 24842A MA 24842 A MA24842 A MA 24842A MA 24383 A1 MA24383 A1 MA 24383A1
Authority
MA
Morocco
Prior art keywords
cephalosporin
pyridinium derivatives
pyridinium
derivatives
Prior art date
Application number
MA24842A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA24383A1 publication Critical patent/MA24383A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24842A 1996-10-22 1997-10-17 Derives pyridinium de cephalosporine MA24383A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96116927 1996-10-22

Publications (1)

Publication Number Publication Date
MA24383A1 true MA24383A1 (fr) 1998-07-01

Family

ID=8223321

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24842A MA24383A1 (fr) 1996-10-22 1997-10-17 Derives pyridinium de cephalosporine

Country Status (23)

Country Link
US (1) US5935950A (fr)
JP (1) JP3004954B2 (fr)
KR (1) KR100253783B1 (fr)
CN (1) CN1184815A (fr)
AR (1) AR009122A1 (fr)
AU (1) AU727502B2 (fr)
BR (1) BR9705113A (fr)
CA (1) CA2214677A1 (fr)
CO (1) CO4910143A1 (fr)
CZ (1) CZ333297A3 (fr)
HR (1) HRP970559A2 (fr)
HU (1) HUP9701661A3 (fr)
IL (1) IL121987A0 (fr)
MA (1) MA24383A1 (fr)
NO (1) NO974759L (fr)
NZ (1) NZ328594A (fr)
PE (1) PE9999A1 (fr)
PL (1) PL322713A1 (fr)
SG (1) SG55392A1 (fr)
TR (1) TR199701185A2 (fr)
TW (1) TW446707B (fr)
YU (1) YU40097A (fr)
ZA (1) ZA979244B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106991A (en) * 1989-09-04 1995-08-30 Pfizer Novel cephalosporin derivatives or compounds
DE69016719T2 (de) * 1989-09-04 1995-06-01 Beecham Group Plc Cephalosporinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate und Zwischenverbindungen.
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
EP0620225B1 (fr) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Dérivés de céphalosporine

Also Published As

Publication number Publication date
AU727502B2 (en) 2000-12-14
KR100253783B1 (ko) 2000-07-01
PL322713A1 (en) 1998-04-27
TR199701185A3 (tr) 1998-05-21
JPH10120687A (ja) 1998-05-12
YU40097A (sh) 1999-12-27
HUP9701661A2 (hu) 1998-11-30
MX9707716A (es) 1998-06-28
NZ328594A (en) 1998-06-26
CO4910143A1 (es) 2000-04-24
HUP9701661A3 (en) 2001-04-28
US5935950A (en) 1999-08-10
TR199701185A2 (xx) 1998-05-21
SG55392A1 (en) 1998-12-21
KR19980033013A (ko) 1998-07-25
BR9705113A (pt) 1998-10-27
HU9701661D0 (en) 1997-12-29
PE9999A1 (es) 1999-02-10
HRP970559A2 (en) 1998-10-31
CA2214677A1 (fr) 1998-04-22
AU4277597A (en) 1998-04-30
NO974759L (no) 1998-04-23
IL121987A0 (en) 1998-03-10
TW446707B (en) 2001-07-21
CZ333297A3 (cs) 1998-05-13
ZA979244B (en) 1998-04-22
JP3004954B2 (ja) 2000-01-31
NO974759D0 (no) 1997-10-15
CN1184815A (zh) 1998-06-17
AR009122A1 (es) 2000-03-08

Similar Documents

Publication Publication Date Title
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
BR9507267A (pt) Antibióticos de cefalosporina
ID16866A (id) Kompleks kompleks inklusi garam-garam aril-heterosiklik
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
NO985177D0 (no) Arrangement for man°vrering av et objekt
BR9509671A (pt) Derivados de dibenzimidazol
MA23970A1 (fr) Derives de cephalosporine
DE69618015T2 (de) Cephalosporinantibiotika
ATE292637T1 (de) Antibakterielle cephalosporine
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
DE69222599T2 (de) Cephalosporin-Derivate
DE69314072D1 (de) Cephalosporin-Derivat
NO992526D0 (no) Cephalosporin-derivater
BR9507892A (pt) Novos derivados de diamino-metilideno
FI973500A (fi) 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset
MA26440A1 (fr) Derives de n-benzylazolium
MX9102186A (es) Derivados de aminodiol
MX9100049A (es) Derivados de aminodiol
MA24383A1 (fr) Derives pyridinium de cephalosporine
BR9506618A (pt) Derivados de difeniloxazolinas
ATE214063T1 (de) Heterocyclische substituierte pyrrolidinamid- derivate
DE69706321D1 (de) Cephemderivate
MA23677A1 (fr) Derives de la cephalosporine
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
BR9603734A (pt) Derivados de cefalosporina